Menopause triggers sudden, sharp shifts across nearly all organ systems and blood markers, according to a study published in Nature Medicine on October 14, 2026. Researchers from Israel’s Weizmann Institute of Science and the Rabin Medical Center analyzed more than 300 million laboratory results to show that the final menstrual period coincides with an abrupt physiological turning point rather than a gradual decline.
Analysis of 300 Million Lab Results Reveals Physiological Cliff
The research team utilized two independent data sources to track changes in women’s health. The first source, the National Health and Nutrition Examination Survey, provided United States-wide lab data spanning from 1998 to 2022. The second source, the Clalit electronic patient record system in Israel, contributed information covering the years 2004 to 2024. Together, these systems yielded over 300 million records from more than one million women.
In western industrialized nations, the final menstrual period typically occurs around age 51, with a general average between 45 and 55 years old worldwide. The data revealed that simultaneous with the menopause transition, jump-like alterations emerged in laboratory values affecting the liver, kidneys, bone metabolism, and lipid profiles, including rising cholesterol levels. Men in the same age bracket exhibited no comparable shifts, prompting the study authors to describe the transition as a physiological cliff.
Hormonal Turbulence Begins a Decade Before Menopause
Accelerated fluctuations in sex hormone levels start more than ten years before the final period, occurring several years earlier than previous scientific models suggested.
Uri Alon, a laboratory head in the molecular cell biology department at the Weizmann Institute, notes that these findings could help women adopt preventive measures like exercise and healthier diets years ahead of the transition. Peyman Hadji, head of the Hormone and Osteoporosis Center in Frankfurt, points out via the Science Media Center that the findings support a systemic understanding of the condition. Hadji states that it extends far beyond reproduction and marks a measurable transition with long-term health consequences.
Contrasting Views on Hormone Therapy and Clinical Prevention
Kai Bühling, head of the hormone consultation clinic at University Medical Center Hamburg-Eppendorf, emphasizes the need to differentiate between the phase of hormonal fluctuations before the final period and the subsequent phase of physiological hormone deficiency. Bühling notes that hormone fluctuations alone can significantly influence blood pressure. Meanwhile, Petra Stute, head of gynecological endocrinology and the menopause center at Bern University Hospital, characterizes the term cliff as somewhat exaggerated, describing menopause as a major physiological adjustment rather than an abrupt onset of disease.
Regarding preventative treatment, Peyman Hadji raises the question of whether menopausal hormone therapy should be applied earlier in women lacking symptoms, given its apparent protective effect against certain chronic conditions. Conversely, Ludwig Kiesel, senior professor at the clinic for gynecology and obstetrics at Münster University Hospital, argues that the observed laboratory shifts do not yet justify prior preventative hormone therapy, maintaining that larger clinical trials must first establish its utility.
Frequently Asked Questions About the Menopause Transition Study
How many patient records did researchers analyze for this study?
The research team examined more than 300 million laboratory results gathered from over one million women in Israel and the United States between 1998 and 2024.
What specific health risks increase following the final menstrual period?
Data from the study show rising rates of type 2 diabetes, cardiovascular diseases, lipid metabolism disorders like high cholesterol, and osteoporosis starting at the time of the final menstruation.
How early do initial hormonal shifts begin before menopause?
Initial alterations in sex hormone levels, including declining estrogen and progesterone concentrations, become detectable up to 15 years prior to the final menstrual period.
Worth a look